Altium Capital Management »

Evoke Pharma shares owned by Altium Capital Management

Quarter-by-quarter ownership of Evoke Pharma (EVOK) shares owned by Altium Capital Management from 13F filings

Historical chart of Altium Capital Management investment in Evoke Pharma

Tip: Access up to 7 years of quarterly data

All positions including Evoke Pharma held by Altium Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Evoke Pharma by Altium Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $442k 725k 0.61

More positions owned by Altium Capital Management

Vera Therapeutics Cl A (VERA)
Xenon Pharmaceuticals (XENE)
Viking Therapeutics Put Put Option
Advisorshares Tr Call Call Option
Axsome Therapeutics (AXSM)
Adma Biologics (ADMA)
Alimera Sciences Com New (ALIM)
Avadel Pharmaceuticals Sponsored Adr (AVDL)
Xtant Med Hldgs Com New (XTNT)
Catalyst Pharmaceutical Partners (CPRX)
Intra Cellular Therapies (ITCI)
Biohaven (BHVN)
Viking Therapeutics (VKTX)
Olema Pharmaceuticals (OLMA)
Savara (SVRA)

View all positions for Altium Capital Management

Top funds holding Evoke Pharma

AIGH Capital Management
Bleichroeder
Altium Capital Management
Nantahala Capital Management
Vanguard Group
Geode Capital Management
Goldman Sachs Group
Millennium Management
Tower Research Capital
BlackRock
UBS Group
Morgan Stanley
Goss Wealth Management
Wells Fargo & Company
Royal Bank of Canada

View all funds holding Evoke Pharma